Data is not available at this time.
Tri Chemical Laboratories Inc. operates in the specialty chemicals sector, focusing on high-purity precursors essential for semiconductors, optical fibers, solar cells, and compound semiconductors. The company’s revenue model is built on supplying niche chemical solutions to advanced manufacturing industries, complemented by a secondary business in specialized containers for high-purity and high-pressure applications. Its product portfolio includes catalysts, reagents, and precision storage solutions, catering to stringent industry requirements. Positioned as a critical supplier in the semiconductor and renewable energy supply chains, Tri Chemical Laboratories benefits from technological advancements driving demand for high-performance materials. The company’s expertise in ultra-pure chemicals and tailored packaging solutions provides a competitive edge in markets where quality and reliability are paramount. With a strong foothold in Japan and potential expansion in global high-tech manufacturing hubs, it maintains a defensible niche amid growing demand for specialized chemical inputs.
Tri Chemical Laboratories reported revenue of JPY 18.9 billion for FY2025, with net income reaching JPY 4.96 billion, reflecting a robust net margin of approximately 26.2%. The company’s operating cash flow stood at JPY 3.68 billion, though capital expenditures of JPY 3.07 billion indicate significant reinvestment. This balance suggests disciplined growth spending while maintaining profitability.
The company’s diluted EPS of JPY 152.69 underscores strong earnings power, supported by its niche market focus. With a cash position of JPY 9.44 billion against total debt of JPY 1.78 billion, Tri Chemical Laboratories demonstrates efficient capital management, leveraging its balance sheet to fund operations and growth without excessive leverage.
Tri Chemical Laboratories maintains a solid financial position, with JPY 9.44 billion in cash and equivalents and modest debt of JPY 1.78 billion. This low leverage ratio, combined with healthy operating cash flow, positions the company to navigate cyclical industry demands while supporting R&D and capacity expansions.
The company’s growth is tied to semiconductor and renewable energy sector trends, with potential upside from global supply chain diversification. A dividend of JPY 35 per share reflects a commitment to shareholder returns, though the payout ratio remains conservative, aligning with reinvestment needs for future expansion.
With a market cap of JPY 90.4 billion and a beta of 1.042, Tri Chemical Laboratories trades with moderate volatility, reflecting its niche but cyclical exposure. Investors likely price in sustained demand for specialty chemicals, though sector-wide capacity shifts could influence valuations.
Tri Chemical Laboratories’ strategic advantage lies in its technical expertise and reliability as a supplier to high-growth industries. The outlook remains positive, driven by secular trends in semiconductor and clean energy adoption, though competitive pressures and input cost volatility warrant monitoring.
Company filings, market data
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |